news Update on the development of new novel cancer immunotherapy 24 May 2019 | By Drug Target Review The SCIB2 vaccine is to to be administered using new nanoparticle formulation in planned Phase 1/2 clinical trial.
webinar A high-throughput approach to developing T-cell immunotherapies 23 May 2019 | By Sartorius Join us as we discuss the promises and pitfalls associated with developing individualised antigen-specific T-cell therapy products for clinical use.
news Key step in the transformation of B-cells to antibody-secreting cells described 8 May 2019 | By Drug Target Review Scientists have detailed the role of a key controlling factor in the transformation of B-cells into antibody-secreting cells.
news New technique developed to expand multimodal single cell analysis 23 April 2019 | By Fraser Owen (Drug Target Review) A new technique, called ECCITE-seq, has been developed to allow researchers to perform high-throughput measurements of multiple modalities of information from single cells.
news Heating up tumours could make CAR T therapy more effective 28 March 2019 | By Drug Target Review When a heating technique called photothermal ablation was combined with the infusion of CAR T cells, it suppressed melanoma tumour growth for up to 20 days in mice...
news How the immune cell ‘Iron Man’ helps T-cells fight infection 20 February 2019 | By Drug Target Review The Iron Man of immune cells, the CD4 cell, has been found to help T-cells fight viral infections, with a lack of these cells often leading to illness...
news Sartorius Stedim Biotech introduces BIOSTAT® RM TX with Flexsafe® RM TX for producing consistent quality cellular products 14 February 2019 | By Sartorius Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry announced the launch of the BIOSTAT® RM TX single-use bioreactor, a new wave mixed system developed specifically for closed, automated expansion of consistent quality cell products such as ex vivo cellular immunotherapies...
product BIOSTAT® RM TX and Flexsafe® RM TX Bags 14 February 2019 | By Sartorius The BIOSTAT® RM TX system consists of an automated control unit and a rocking platform, for gently agitating a single-use Flexsafe® RM bag...
product Intellicyt® T Cell Activation Cell and Cytokine Profiling Kit 17 January 2019 | By IntelliCyt, a Sartorius Company Multiplexed approach to measure T-cell activation, proliferation and quantify cytokine release in a single well
news Engineered T-cells promote acceptance of organs after transplant 15 January 2019 | By Iqra Farooq (Drug Target Review) Controlling coronin 1 in T-cells could lead to the immune system not attacking transplanted organs, but still fighting other infections...
news New therapeutic concept controls pathogenic T-cells relevant in MS 14 January 2019 | By Dr Zara Kassam (Drug Target Review) Researchers have identified an innovative and promising therapeutic option to treat multiple sclerosis...
news Phospholipid reactive T-cells could play a role in cancer 7 December 2018 | By Drug Target Review Phospholipid-reactive T-cells that are able to recognise phospholipids could help in treatments against cancer, autoimmune diseases and dyslipidemia...
news T-cells engineered to recognise tumours expressing the CD30 protein marker 4 December 2018 | By Drug Target Review Researchers have genetically engineered immune cells to recognise and fight Hodgkin and non-Hodgkin lymphoma cells...
news War On Cancer 2018: targeted therapies in oncology 21 November 2018 | By Iqra Farooq (Drug Target Review) War On Cancer 2018 discussed how cancer treatments have evolved over the last few decades, and looked at the future of cancer therapies...
news RIP1 kinase as a therapeutic target for pancreatic cancer 12 November 2018 | By Iqra Farooq (Drug Target Review) RIP1 has been shown to suppress the action of macrophages against the immune system and could be a potential therapeutic target for pancreatic cancer...
